Literature DB >> 28228280

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.

Hung N Nguyen1, Erika H Noss1, Fumitaka Mizoguchi2, Christine Huppertz3, Kevin S Wei1, Gerald F M Watts1, Michael B Brenner4.   

Abstract

Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1α, and IL-1β. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-33; IL-6; IL-8; LIF; LIFR; STAT4; fibroblasts; interleukin-33; interleukin-6; interleukin-8; leukemia inhibitor factor; leukemia inhibitor factor receptor; rheumatoid arthritis; signal transducer and activator of transcription 4; stromal cells; synovium

Mesh:

Substances:

Year:  2017        PMID: 28228280      PMCID: PMC5567864          DOI: 10.1016/j.immuni.2017.01.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  55 in total

Review 1.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.

Authors:  H Okamoto; M Yamamura; Y Morita; S Harada; H Makino; Z Ota
Journal:  Arthritis Rheum       Date:  1997-06

3.  Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.

Authors:  V Pitard; J L Taupin; V Miossec; F Blanchard; M Cransac; I Jollet; A Vernallis; K Hudson; A Godard; Y Jacques; J F Moreau
Journal:  J Immunol Methods       Date:  1997-07-14       Impact factor: 2.303

Review 4.  Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.

Authors:  Maximilian J Waldner; Markus F Neurath
Journal:  Semin Immunol       Date:  2014-01-18       Impact factor: 11.130

Review 5.  The neuropoietic cytokine family in development, plasticity, disease and injury.

Authors:  Sylvian Bauer; Bradley J Kerr; Paul H Patterson
Journal:  Nat Rev Neurosci       Date:  2007-03       Impact factor: 34.870

6.  Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro.

Authors:  Hans P Kiener; David M Lee; Sandeep K Agarwal; Michael B Brenner
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domains.

Authors:  J L Taupin; P Legembre; J Bitard; S Daburon; V Pitard; F Blanchard; L Duplomb; A Godard; Y Jacques; J F Moreau
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

8.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

9.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 10.  LIF-STAT signaling and trophoblast biology.

Authors:  Pankaj Suman; Sudha Saryu Malhotra; Satish Kumar Gupta
Journal:  JAKSTAT       Date:  2013-06-27
View more
  48 in total

1.  Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Authors:  Bikash Sahay; Kathleen Bashant; Nicole L J Nelson; Rebeca L Patsey; Shiva Kumar Gadila; Rebecca Boohaker; Ashutosh Verma; Klemen Strle; Timothy J Sellati
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation.

Authors:  Yanan S Zhang; Dazhuan E Xin; Zhizhang Wang; Xinyang Song; Yanyun Sun; Quanli C Zou; Jichen Yue; Chenxi Zhang; Junxun M Zhang; Zhi Liu; Xiaoren Zhang; Ting C Zhao; Bing Su; Y Eugene Chin
Journal:  EMBO J       Date:  2019-02-15       Impact factor: 11.598

3.  Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells.

Authors:  Yeonjin Kim; Mark S Sundrud; Changqian Zhou; Maja Edenius; Davide Zocco; Kristen Powers; Miao Zhang; Ralph Mazitschek; Anjana Rao; Chang-Yeol Yeo; Erika H Noss; Michael B Brenner; Malcolm Whitman; Tracy L Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

4.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

Review 5.  The mesenchymal context in inflammation, immunity and cancer.

Authors:  Vasiliki Koliaraki; Alejandro Prados; Marietta Armaka; George Kollias
Journal:  Nat Immunol       Date:  2020-08-03       Impact factor: 25.606

Review 6.  Importance of lymphocyte-stromal cell interactions in autoimmune and inflammatory rheumatic diseases.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 20.543

7.  Combined targeting of EGFR and HER2 against prostate cancer stem cells.

Authors:  Anna Rossini; Marta Giussani; Francesca Ripamonti; Piera Aiello; Viola Regondi; Andrea Balsari; Tiziana Triulzi; Elda Tagliabue
Journal:  Cancer Biol Ther       Date:  2020-02-23       Impact factor: 4.742

Review 8.  Fibroblasts as immune regulators in infection, inflammation and cancer.

Authors:  Sarah Davidson; Mark Coles; Tom Thomas; George Kollias; Burkhard Ludewig; Shannon Turley; Michael Brenner; Christopher D Buckley
Journal:  Nat Rev Immunol       Date:  2021-04-28       Impact factor: 53.106

Review 9.  IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry.

Authors:  Saikat Majumder; Mandy J McGeachy
Journal:  Annu Rev Immunol       Date:  2021-02-12       Impact factor: 28.527

10.  JAK Inhibitors Suppress Cancer Cachexia-Associated Anorexia and Adipose Wasting in Mice.

Authors:  Gurpreet Arora; Arun Gupta; Tong Guo; Aakash Gandhi; Aaron Laine; Dorothy Williams; Chul Ahn; Puneeth Iyengar; Rodney Infante
Journal:  JCSM Rapid Commun       Date:  2020-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.